Hello, I am Dr. Hidenori Shimada of Grand Green Osaka Umekita Clinic in Osaka, Japan.
NK cell (Natural Killer cell) therapy is a form of cancer immunotherapy that harnesses the body’s own immune system to fight cancer. While it represents a promising approach for some patients, it’s important to understand that treatment outcomes can vary significantly from person to person. A key question many individuals and their families have is: why do some people respond well to NK cell therapy while others do not? The answer is not simple and involves a complex interplay of multiple factors.
This article explores the primary reasons behind the variability in NK cell therapy outcomes. By understanding these factors, patients can have a more realistic perspective and engage in more informed discussions with their healthcare providers. The effectiveness of this therapy depends on the specific characteristics of the cancer, the patient’s overall health and immune status, and the treatment protocol itself.
Key Factors Influencing Treatment Response
The response to NK cell therapy is not determined by a single element but by a combination of conditions. Major influences include the nature of the cancer, the patient’s unique biological landscape, and lifestyle choices. Acknowledging this complexity is the first step toward understanding potential treatment paths.
The Nature of the Cancer Itself
Not all cancers are the same, and their individual characteristics play a crucial role in how they interact with the immune system, including administered NK cells.
- Tumor Type and Characteristics: Some types of cancer are inherently more recognizable by NK cells. NK cells are adept at identifying and attacking cells that have lost their “self” markers (MHC class I molecules), a common tactic some cancer cells use to evade other immune cells like T cells. Tumors with low MHC expression may be better targets for NK cells.
- The Tumor Microenvironment (TME): Cancer cells exist within a complex ecosystem known as the tumor microenvironment. This environment can be hostile to immune cells. Some tumors create an immunosuppressive TME, releasing signals that deactivate or exhaust NK cells, preventing them from mounting an effective attack.
- Cancer Stage and Tumor Burden: The overall amount of cancer in the body (tumor burden) can also influence outcomes. In cases of advanced or widespread disease, the sheer number of cancer cells may overwhelm the infused NK cells, making it more challenging to achieve a significant clinical response.
The Patient’s Immune System and Overall Health
The patient’s own body is the battlefield where this therapy takes place. Therefore, their general health and the state of their immune system are fundamental to the potential success of the treatment.
- Baseline Immune Function: Each person’s immune system is unique. The initial number and activity level of a patient’s own NK cells can impact the effectiveness of the therapy. Factors like age, chronic stress, and nutritional status are known to affect immune function, including NK cell activity.
- Overall Health and Coexisting Conditions: A patient’s general health status can influence their ability to tolerate treatment and respond to it. Other medical conditions may affect the body’s internal environment and its support for the infused immune cells.
- Previous Treatments: Prior cancer treatments, such as chemotherapy or radiation, can impact the immune system. While NK cell therapy can sometimes be combined with these standard treatments, the effects of prior therapies on bone marrow and overall immunity must be considered.
Treatment Protocols and Lifestyle Factors
The specifics of how NK cell therapy is administered, as well as a patient’s lifestyle, can also contribute to the variability in outcomes.
- Cell Preparation and Dosage: The methods used to collect, activate, and expand the NK cells in the laboratory can affect their potency. The total number of cells administered and the frequency of infusions are also critical parameters that are tailored to the individual’s condition.
- Combination with Other Therapies: NK cell therapy is often considered not as a replacement for standard treatments but as a complementary approach. Its effectiveness may be enhanced when used in combination with other treatments like chemotherapy, radiation, or antibody drugs that can make cancer cells more vulnerable to NK cell attack.
- Lifestyle and Supportive Care: While not a direct treatment, factors like a balanced diet, adequate sleep, and stress management can support overall immune health. A healthier internal environment may provide a more favorable setting for the therapeutic NK cells to function.
What to Discuss Before Considering Treatment
Given these variables, a thorough consultation with a physician is essential. It is important to have a clear understanding of what the therapy may or may not achieve for your specific situation. This treatment is not a guaranteed cure, and its suitability must be carefully evaluated by a medical professional.
Please note that NK cell therapy is provided as a private medical service (not covered by national health insurance). In Japan, such treatments are offered under regulations like the Act on the Safety of Regenerative Medicine. A physician’s diagnosis is required to determine if you are a suitable candidate. During your consultation, you should discuss the potential benefits, expected number of sessions, treatment duration, as well as the risks and side effects, which may include temporary fever or fatigue.
Exploring NK Cell Therapy in Osaka
At Grand Green Osaka Umekita Clinic, located in the Umeda area of Osaka, we provide detailed consultations for patients considering NK cell therapy. Our approach is to help you understand the treatment in the context of your personal health situation. We believe that an informed patient is better equipped to make decisions about their care plan.
For more comprehensive information on our NK cell therapy, including the process, features, and potential costs, we encourage you to visit our dedicated service page. We also provide information for our international patients.
Learn more about NK Cell Therapy at our clinic.A Realistic Perspective on NK Cell Therapy
In conclusion, the outcomes of NK cell therapy are highly individualized. The response is influenced by a wide array of factors, from the molecular details of the cancer to the patient’s overall health. This variability underscores the importance of personalized medicine and highlights why a one-size-fits-all approach is not applicable. The goal of this therapy is often to work alongside standard treatments to help manage the disease and improve quality of life. Making an informed decision in close consultation with your medical team is the most critical step in this journey.
- Nature of the CancerTumor type, environment, and burden
- Patient's Health & ImmunityImmunity, overall health, prior treatments
- Treatment & LifestyleDosage, combination therapies, lifestyle
This diagram summarizes the key factors discussed in the article
References
- PubMed: Characterizing cancer metabolism from bulk and single-cell RNA-seq data using METAFlux. (2023)
- PubMed: Efficacy and safety of natural killer cell therapy in patients with solid tumors: a systematic review and meta-analysis. (2024)
- PubMed: Phenotypic and transcriptomic profiling of induced pluripotent stem cell (iPSC)-derived NK cells and their cytotoxicity against cancers. (2024)
- PubMed: Loss of metabolic fitness drives tumor resistance after CAR-NK cell therapy and can be overcome by cytokine engineering. (2023)
- PubMed: Induced pluripotent stem-cell-derived CD19-directed chimeric antigen receptor natural killer cells in B-cell lymphoma: a phase 1, first-in-human trial. (2025)
- PMC: Immunotherapy for sarcomas: new frontiers and unveiled opportunities. (2021)
- PMC: Immunotherapy for Glioblastoma: Current Progress and Challenges. (2021)
- PMC: Precision medicine in nasopharyngeal carcinoma: comprehensive review of past, present, and future prospect. (2023)
- MHLW (Japan): Regenerative Medicine — Ministry of Health, Labour and Welfare, Japan
Supervising Physician
Director, Medical Corporation Shimada Clinic
Head of Clinical Practice, Grand Green Osaka Umekita Clinic
Hidenori Shimada
Graduated from the University of Tokushima Faculty of Medicine in 2005. After his initial residency, he obtained U.S. medical certification (ECFMG) and trained as a sub-intern in general surgery at the University of Washington. After completing the doctoral program at Kyoto University Graduate School of Medicine and working as a researcher at the Center for iPS Cell Research and Application (CiRA), Kyoto University, he founded Shimada Clinic in 2013. At Grand Green Osaka Umekita Clinic (https://umekitaclinic.org), he is engaged in a wide range of care, from internal medicine and pediatrics to cell therapy and aesthetic medicine.
* The physician supervision of this article covers its academic content only and does not constitute a recommendation of any specific treatment or product.